HN1998000102A - Composiciones solubilizadas de sertralina - Google Patents

Composiciones solubilizadas de sertralina

Info

Publication number
HN1998000102A
HN1998000102A HN1998000102A HN1998000102A HN1998000102A HN 1998000102 A HN1998000102 A HN 1998000102A HN 1998000102 A HN1998000102 A HN 1998000102A HN 1998000102 A HN1998000102 A HN 1998000102A HN 1998000102 A HN1998000102 A HN 1998000102A
Authority
HN
Honduras
Prior art keywords
soltrilized
sertralina
compositions
present
invention refers
Prior art date
Application number
HN1998000102A
Other languages
English (en)
Spanish (es)
Inventor
Pfizer Products Inc
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21971159&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HN1998000102(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of HN1998000102A publication Critical patent/HN1998000102A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0002Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2009Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183Amino acids, e.g. glycine, EDTA or aspartame

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HN1998000102A 1997-07-01 1998-07-01 Composiciones solubilizadas de sertralina HN1998000102A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5141397P 1997-07-01 1997-07-01

Publications (1)

Publication Number Publication Date
HN1998000102A true HN1998000102A (es) 1999-01-08

Family

ID=21971159

Family Applications (1)

Application Number Title Priority Date Filing Date
HN1998000102A HN1998000102A (es) 1997-07-01 1998-07-01 Composiciones solubilizadas de sertralina

Country Status (34)

Country Link
EP (1) EP0999829A1 (ru)
JP (1) JP2000514100A (ru)
KR (1) KR100366373B1 (ru)
CN (1) CN1261794A (ru)
AP (1) AP1192A (ru)
AR (3) AR015917A1 (ru)
AU (1) AU742535B2 (ru)
BG (1) BG103918A (ru)
BR (1) BR9810739A (ru)
CA (1) CA2290974C (ru)
CO (1) CO4940495A1 (ru)
DZ (1) DZ2548A1 (ru)
EA (1) EA002481B1 (ru)
HN (1) HN1998000102A (ru)
HR (1) HRP980377A2 (ru)
HU (1) HUP0002236A3 (ru)
ID (1) ID23429A (ru)
IL (1) IL133076A (ru)
IS (1) IS5260A (ru)
MA (1) MA24587A1 (ru)
NO (1) NO996520L (ru)
OA (1) OA11243A (ru)
PA (1) PA8454301A1 (ru)
PE (1) PE97199A1 (ru)
PL (1) PL337804A1 (ru)
SK (1) SK181099A3 (ru)
TN (1) TNSN98124A1 (ru)
TR (1) TR199903297T2 (ru)
TW (1) TW550087B (ru)
UA (1) UA67741C2 (ru)
UY (1) UY25071A1 (ru)
WO (1) WO1999001120A1 (ru)
YU (1) YU68299A (ru)
ZA (1) ZA985708B (ru)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA02006324A (es) 1999-12-23 2002-12-13 Pfizer Prod Inc Composiciones farmaceuticas que proporcionan concentraciones potenciadas de farmaco.
US20030086972A1 (en) * 2000-08-09 2003-05-08 Appel Leah E. Hydrogel-driven drug dosage form
EP1313473A2 (en) 2000-08-30 2003-05-28 Pfizer Products Inc. Sustained release formulations for growth hormone secretagogues
US20040191207A1 (en) * 2003-03-31 2004-09-30 Lipari John M. Alpha-hydroxy acid ester drug delivery compositions and methods of use
EP2117652B1 (en) * 2007-03-12 2013-09-25 DSM IP Assets B.V. Cosmetic compositions
KR20120116422A (ko) * 2009-12-29 2012-10-22 코와 가부시키가이샤 경구 투여용 의약 조성물
WO2011081117A1 (ja) * 2009-12-29 2011-07-07 興和株式会社 経口投与用固形医薬組成物
CN109908354A (zh) * 2017-12-12 2019-06-21 万特制药(海南)有限公司 盐酸舍曲林口服浓缩液及其制备工艺

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4803076A (en) * 1986-09-04 1989-02-07 Pfizer Inc. Controlled release device for an active substance
DK0415612T3 (da) * 1989-08-30 1993-12-13 Pfizer Anvendelse af sertralin til behandling af afhængigheder af kemiske stoffer
ZA97976B (en) * 1996-04-05 1997-08-18 Alza Corp Uniform drug delivery theraphy.

Also Published As

Publication number Publication date
BG103918A (en) 2000-07-31
AU742535B2 (en) 2002-01-03
IL133076A (en) 2003-12-10
IS5260A (is) 1999-11-19
CN1261794A (zh) 2000-08-02
CA2290974C (en) 2004-04-27
HUP0002236A3 (en) 2003-12-29
KR100366373B1 (ko) 2003-01-14
CO4940495A1 (es) 2000-07-24
JP2000514100A (ja) 2000-10-24
DZ2548A1 (fr) 2003-02-08
ID23429A (id) 2000-04-20
TNSN98124A1 (fr) 2005-03-15
HUP0002236A2 (hu) 2003-08-28
EA199900962A1 (ru) 2000-08-28
PE97199A1 (es) 1999-10-05
CA2290974A1 (en) 1999-01-14
SK181099A3 (en) 2000-07-11
NO996520D0 (no) 1999-12-28
EP0999829A1 (en) 2000-05-17
PA8454301A1 (es) 2000-09-29
AP9801280A0 (en) 1998-06-30
MA24587A1 (fr) 1998-12-31
AR015917A1 (es) 2001-05-30
AR040279A2 (es) 2005-03-23
KR20010013365A (ko) 2001-02-26
UA67741C2 (ru) 2004-07-15
ZA985708B (en) 2000-01-10
AU7544898A (en) 1999-01-25
UY25071A1 (es) 2000-12-29
YU68299A (sh) 2002-06-19
EA002481B1 (ru) 2002-06-27
AP1192A (en) 2003-07-23
TR199903297T2 (xx) 2000-07-21
WO1999001120A1 (en) 1999-01-14
OA11243A (en) 2003-07-24
AR040280A2 (es) 2005-03-23
HRP980377A2 (en) 1999-04-30
NO996520L (no) 2000-02-29
BR9810739A (pt) 2000-09-12
TW550087B (en) 2003-09-01
PL337804A1 (en) 2000-09-11
IL133076A0 (en) 2001-03-19

Similar Documents

Publication Publication Date Title
HN1999000089A (es) Formulaciones de ziprasidona
HN1998000086A (es) Derivados de 9 - desofo - 9 aza - 9a - homoeritromicina a - c - 4 sustituidos.
HN1998000036A (es) Compuesto de pirazina
HN1998000011A (es) Derivados de acidos arilsulfonilaminohidroxamicos
HN1999000155A (es) 4-carboxiamino-2-metil-1,2,3,4-tetrahidroquinolinas
HN1997000090A (es) Compuestos de piridilpirrol
HN1997000166A (es) 1-arilpirazoles plaguicidas
HN1999000066A (es) Formulaciones farmaceuticas
HN1997000023A (es) Derivados de lactama
HN1998000132A (es) Combinaciones terapeuticas
HN1998000057A (es) Derivados de nicotinamida
HN1997000126A (es) Derivados de indazol
HN1998000030A (es) 2-amino-6-(4fenoxi-2-sustituido)-piridinas sustituidas
HN1998000124A (es) Terapia de combinacion
HN1998003689A (es) Azetidinas
HN1998000106A (es) Composiciones parenterales de alatroflaxacino
HN1998000158A (es) Isoquinolinas
HN1998000028A (es) Otropisomeros de 3 heteroaril - 4 (3h) - quinazolinonas.
HN1998000045A (es) Composiciones farmaceuticas
HN1998000199A (es) Agentes terapeuticos
HN1998000193A (es) Compuestos de triazina
HN1998000102A (es) Composiciones solubilizadas de sertralina
HN1998000165A (es) Polimorfos dofetilina
HN1999000202A (es) Derivados de higromicina
HN1997000119A (es) Formulaciones repelente